Literature DB >> 10070875

High efficiency of benzoporphyrin derivative in the photodynamic therapy of pigmented malignant melanoma.

A Busetti1, M Soncin, G Jori, M A Rodgers.   

Abstract

Benzoporphyrin derivative monoacid ring A (verteporfin, BPD-MA) when intravenously injected (5.5 micromol kg(-1)) to C57/BL6 mice bearing a subcutaneously transplanted B1 melanoma gave a maximal accumulation in the tumour within 1-3 h with recoveries of 1.84-1.96 micromol kg(-1). Irradiation of BPD-MA-loaded melanoma with 690-nm light from a dye laser at 3 h and 9 h post injection induced tumour necrosis and delay of tumour growth of 28 and 14 days respectively. The response of the tumour to BPD-MA photosensitization was enhanced by pretreatment with 1064-nm light from a pulse-operated Nd:YAG laser, which caused a selective breakdown of melanosomes.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10070875      PMCID： PMC2362652          DOI： 10.1038/sj.bjc.6690131

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


  9 in total

1.  Effect of photosensitizer delivery system and irradiation parameters on the efficiency of photodynamic therapy of B16 pigmented melanoma in mice.

Authors:  R Biolo; G Jori; M Soncin; B Rihter; M E Kenney; M A Rodgers
Journal:  Photochem Photobiol       Date:  1996-02       Impact factor: 3.421

Review 2.  New applications in photodynamic therapy. Introduction.

Authors:  J G Levy; M Obochi
Journal:  Photochem Photobiol       Date:  1996-11       Impact factor: 3.421

3.  Biodistribution of tritiated benzoporphyrin derivative (3H-BPD-MA), a new potent photosensitizer, in normal and tumor-bearing mice.

Authors:  A M Richter; S Cerruti-Sola; E D Sternberg; D Dolphin; J G Levy
Journal:  J Photochem Photobiol B       Date:  1990-04-15       Impact factor: 6.252

Review 4.  Photosensitizers: therapy and detection of malignant tumors.

Authors:  T J Dougherty
Journal:  Photochem Photobiol       Date:  1987-06       Impact factor: 3.421

5.  Histological comparison of the B16 melanoma and its F1 variant.

Authors:  T J Wosko; D T Ferrara; L S Sartori
Journal:  Cancer Lett       Date:  1984-08       Impact factor: 8.679

6.  The effects of plasma lipoproteins on in vitro tumor cell killing and in vivo tumor photosensitization with benzoporphyrin derivative.

Authors:  B A Allison; E Waterfield; A M Richter; J G Levy
Journal:  Photochem Photobiol       Date:  1991-11       Impact factor: 3.421

7.  Photodynamic therapy of B16 pigmented melanoma with liposome-delivered Si(IV)-naphthalocyanine.

Authors:  R Biolo; G Jori; M Soncin; R Pratesi; U Vanni; B Rihter; M E Kenney; M A Rodgers
Journal:  Photochem Photobiol       Date:  1994-03       Impact factor: 3.421

8.  Treatment of malignant melanoma by high-peak-power 1064 nm irradiation followed by photodynamic therapy.

Authors:  A Busetti; M Soncin; G Jori; M E Kenney; M A Rodgers
Journal:  Photochem Photobiol       Date:  1998-09       Impact factor: 3.421

9.  Liposome-delivered Si(IV)-naphthalocyanine as a photodynamic sensitiser for experimental tumours: pharmacokinetic and phototherapeutic studies.

Authors:  V Cuomo; G Jori; B Rihter; M E Kenney; M A Rodgers
Journal:  Br J Cancer       Date:  1990-12       Impact factor: 7.640
  9 in total
  7 in total

1.  Stable synthetic bacteriochlorins overcome the resistance of melanoma to photodynamic therapy.

Authors:  Pawel Mroz; Ying-Ying Huang; Angelika Szokalska; Timur Zhiyentayev; Sahar Janjua; Artemissia-Phoebe Nifli; Margaret E Sherwood; Christian Ruzié; K Eszter Borbas; Dazhong Fan; Michael Krayer; Thiagarajan Balasubramanian; Eunkyung Yang; Hooi Ling Kee; Christine Kirmaier; James R Diers; David F Bocian; Dewey Holten; Jonathan S Lindsey; Michael R Hamblin
Journal:  FASEB J       Date:  2010-04-12       Impact factor: 5.191

2.  The effectiveness and safety of X-PDT for cutaneous squamous cell carcinoma and melanoma.

Authors:  Lei Shi; Pei Liu; Jing Wu; Lun Ma; Han Zheng; Michael P Antosh; Haiyan Zhang; Bo Wang; Wei Chen; Xiuli Wang
Journal:  Nanomedicine (Lond)       Date:  2019-06-05       Impact factor: 5.307

3.  Association studies to transporting proteins of fac-ReI(CO)3(pterin)(H2O) complex.

Authors:  Fabricio Ragone; Héctor H Martínez Saavedra; Pablo F García; Ezequiel Wolcan; Gerardo A Argüello; Gustavo T Ruiz
Journal:  J Biol Inorg Chem       Date:  2016-11-04       Impact factor: 3.358

Review 4.  Melanoma resistance to photodynamic therapy: new insights.

Authors:  Ying-Ying Huang; Daniela Vecchio; Pinar Avci; Rui Yin; Maria Garcia-Diaz; Michael R Hamblin
Journal:  Biol Chem       Date:  2013-02       Impact factor: 3.915

5.  Label-Free, Longitudinal Visualization of PDT Response In Vitro with Optical Coherence Tomography.

Authors:  Yookyung Jung; Alexander J Nichols; Oliver J Klein; Emmanuel Roussakis; Conor L Evans
Journal:  Isr J Chem       Date:  2012-09-13       Impact factor: 3.333

6.  Photodynamic therapy of melanoma using new, synthetic porphyrins and phthalocyanines as photosensitisers - a comparative study.

Authors:  Ioana Baldea; Rodica-Mariana Ion; Diana Elena Olteanu; Iuliana Nenu; Diana Tudor; Adriana Gabriela Filip
Journal:  Clujul Med       Date:  2015-04-15

7.  In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis.

Authors:  Seohyun Kim; Seong A Kim; Gi-Hoon Nam; Yeonsun Hong; Gi Beom Kim; Yoonjeong Choi; Seokyoung Lee; Yuri Cho; Minsu Kwon; Cherlhyun Jeong; Sehoon Kim; In-San Kim
Journal:  J Immunother Cancer       Date:  2021-01       Impact factor: 13.751
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.